Thomas K. Equels - 13 Dec 2021 Form 4/A - Amendment Insider Report for AIM ImmunoTech Inc. (AIMI)

Role
CEO & President, Director
Signature
Thomas K. Equels
Issuer symbol
AIMI
Transactions as of
13 Dec 2021
Net transactions value
+$25,000
Form type
4/A - Amendment
Filing time
13 Dec 2021, 10:43:08 UTC
Date Of Original Report
13 Dec 2021
Previous filing
10 Dec 2021
Next filing
04 Mar 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AIM Common Stock Award $25,000 +21,552 +7.7% $1.16 300,789 13 Dec 2021 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Form amended to include reporting person is a director and officer.